ANI PHARMACEUTICALS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $67.3M | $197.3M | $43.0M |
| FY2019 | $175.8M | $212.8M | $62.3M |
| FY2020 | $172.4M | $195.7M | $7.9M |
| FY2021 | $286.5M | $333.9M | $100.3M |
| FY2022 | $285.7M | $313.7M | $48.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $67.3M | $197.3M | $43.0M |
| FY2019 | $175.8M | $212.8M | $62.3M |
| FY2020 | $172.4M | $195.7M | $7.9M |
| FY2021 | $286.5M | $333.9M | $100.3M |
| FY2022 | $285.7M | $313.7M | $48.2M |